1. Abra, R.M., and C.A., Hunt, 1981, Liposome disposition in vivo. III. Dose and vesicle-size effects. Biochim. Biophys. Acta, 666:493.
2. Ahmad, I., and Allen, T.M., 1992, Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. Cancer Res. 52:4817.
3. Ahmad, I., Longenecker, M., Samuel, J., and Allen, T.M., 1993, Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res. 53:1484.
4. Allen, T.M., 1994, The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv. Drug Del Rev. 13:285.
5. Allen, T.M., Agrawal, A.K., Ahmad, I., Hansen C.B., and Zalipsky, S., 1994, Antibody-mediated targeting of long-circulating (Stealth®) liposomes. J. Liposome Res. 4:1.